Showing 8,541 - 8,560 results of 60,129 for search '(( 5 ((we decrease) OR (teer decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 8541

    Meta-analytical results of secondary outcomes. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…</p><p>Results</p><p>Twenty-three RCTs (mean dosage 5mg to 300mg amitriptyline/day) and 4217 patients (mean age 40.3 years) were included. …”
  2. 8542

    Study characteristics. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…</p><p>Results</p><p>Twenty-three RCTs (mean dosage 5mg to 300mg amitriptyline/day) and 4217 patients (mean age 40.3 years) were included. …”
  3. 8543

    Forest plots of primary outcomes. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…</p><p>Results</p><p>Twenty-three RCTs (mean dosage 5mg to 300mg amitriptyline/day) and 4217 patients (mean age 40.3 years) were included. …”
  4. 8544
  5. 8545
  6. 8546

    Data_Sheet_2_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf by Artur Balasa (12564976)

    Published 2022
    “…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
  7. 8547

    Data_Sheet_1_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf by Artur Balasa (12564976)

    Published 2022
    “…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
  8. 8548

    Data_Sheet_1_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf by Artur Balasa (12564976)

    Published 2022
    “…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
  9. 8549

    Data_Sheet_2_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf by Artur Balasa (12564976)

    Published 2022
    “…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
  10. 8550

    The YPLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  11. 8551

    Characteristics of selected studies. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  12. 8552

    The SEYLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  13. 8553

    Data extraction form. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  14. 8554

    Patterns of SEYLL rate by WHO regions. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  15. 8555

    Distribution of selected studies by country. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…A literature search for eligible studies was conducted in five electronic databases: PubMed, Scopus, Web of Science (WoS), and the Cochrane Central Register of Controlled Trials (CENTRAL). …”
  16. 8556

    Supplementary Material for: miR-155-5p is Negatively Associated with Acute Pancreatitis and Inversely Regulates Pancreatic Acinar Cell Progression by Targeting Rela and Traf3 by Liu S. (3777670)

    Published 2018
    “…In addition, we treated caerulein- and TLC-S-induced AR42J cells with the <i>Rela</i> inhibitor helenalin and found that the expression of <i>Rela, Traf3</i> and <i>Ptgs2</i> decreased compared with the NC, while the expression of miR-155-5p did not show any significant difference. …”
  17. 8557
  18. 8558
  19. 8559
  20. 8560

    Image_5_Taxonomic and Functional Characterization of the Microbial Community During Spontaneous in vitro Fermentation of Riesling Must.TIFF by Kimmo Sirén (6567302)

    Published 2019
    “…During alcoholic fermentation, we observed a general decrease in biodiversity in both the metabarcoding and metagenomic data. …”